Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

75%

3 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
3(100.0%)
3Total
Phase 3(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06168591Unknown

Longitudinal Neuromuscular and Metabolic Changes With Aging

Role: collaborator

NCT01050972Phase 3Unknown

Effectiveness of a Cognitive and Physical Intervention to Reduce Head and Muscle Pain in a Large Population

Role: collaborator

NCT00551980Phase 3Completed

The Efficacy of a Cognitive and Physical Intervention to Reduce Head and Muscle Pain in a Working Community

Role: collaborator

NCT00457496Phase 3Completed

Effectiveness of a Cognitive and Physical Intervention to Reduce Head and Muscle Pain in Working Communities

Role: collaborator

All 4 trials loaded